TABLE 3.
Week 4 Characteristics at Randomization in Patients Who Remained on Every Other Week Dosing and Who Escalated to Blinded Weekly Dosing After Week 12
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.